203 related articles for article (PubMed ID: 11571737)
21. Clinicopathologic significance of expression of CD44s and CD44v6 isoforms in squamous cell carcinoma of the supraglottic larynx.
Rodrigo JP; Domínguez F; Alvarez C; González MV; Herrero A; Suárez C
Am J Clin Pathol; 2002 Jul; 118(1):67-72. PubMed ID: 12109858
[TBL] [Abstract][Full Text] [Related]
22. [Expression of CD44 variant exon 6 in lung cancers].
Wang FL; Wei LX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):401-2. PubMed ID: 12940087
[TBL] [Abstract][Full Text] [Related]
23. High frequency expressions of CD44 standard and variant forms in non-small cell lung cancers, but not in small cell lung cancers.
Kondo K; Miyoshi T; Hino N; Shimizu E; Masuda N; Takada M; Uyama T; Monden Y
J Surg Oncol; 1998 Nov; 69(3):128-36. PubMed ID: 9846498
[TBL] [Abstract][Full Text] [Related]
24. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer.
Shimabukuro K; Toyama-Sorimachi N; Ozaki Y; Goi T; Furukawa K; Miyasaka M; Aso T
Gynecol Oncol; 1997 Jan; 64(1):26-34. PubMed ID: 8995543
[TBL] [Abstract][Full Text] [Related]
25. CD44 loss in gastric stromal tumors as a prognostic marker.
Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
[TBL] [Abstract][Full Text] [Related]
26. Expression of CD44 in primary lung carcinomas using histological and cytological analyses.
Shimbori M; Kijima H; Sato S; Yoshida H; Sato T; Terasaki-Fukuzawa Y; Onoda N; Kanabuchi K; Abe Y; Nakamura M; Hattori M; Ohno E; Kuramoto H
Anticancer Res; 2003; 23(1A):115-21. PubMed ID: 12680202
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
[TBL] [Abstract][Full Text] [Related]
28. Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells.
Montero-Montero L; Renart J; Ramírez A; Ramos C; Shamhood M; Jarcovsky R; Quintanilla M; Martín-Villar E
Cells; 2020 Sep; 9(10):. PubMed ID: 33003440
[TBL] [Abstract][Full Text] [Related]
29. Distinct expression patterns of CD44 isoforms during human lung development and in pulmonary fibrosis.
Kasper M; Günthert U; Dall P; Kayser K; Schuh D; Haroske G; Müller M
Am J Respir Cell Mol Biol; 1995 Dec; 13(6):648-56. PubMed ID: 7576702
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analyses of CD44 variant isoforms in invasive micropapillary carcinoma of the breast: comparison with a concurrent conventional invasive carcinoma of no special type component.
Umeda T; Ishida M; Murata S; Mori T; Kawai Y; Itoi N; Tomida K; Tanaka A; Sakai S; Kitamura M; Kubota Y; Kushima R; Tani M
Breast Cancer; 2016 Nov; 23(6):869-875. PubMed ID: 26494575
[TBL] [Abstract][Full Text] [Related]
31. Preneoplastic lesions of the lung.
Greenberg AK; Yee H; Rom WN
Respir Res; 2002; 3(1):20. PubMed ID: 11980589
[TBL] [Abstract][Full Text] [Related]
32. Restoration of CD44S in non-small cell lung cancer cells enhanced their susceptibility to the macrophage cytotoxicity.
Takahashi K; Takahashi F; Hirama M; Tanabe KK; Fukuchi Y
Lung Cancer; 2003 Aug; 41(2):145-53. PubMed ID: 12871777
[TBL] [Abstract][Full Text] [Related]
33. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients.
Li Z; Chen K; Jiang P; Zhang X; Li X; Li Z
Diagn Pathol; 2014 Apr; 9():79. PubMed ID: 24708709
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of CD44v6 in metastases of intestinal and diffuse types of gastric carcinoma.
Castellà EM; Ariza A; Pellicer I; Fernández-Vasalo A; Ojanguren I
J Clin Pathol; 1998 Feb; 51(2):134-7. PubMed ID: 9602687
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
Rusch V; Klimstra D; Linkov I; Dmitrovsky E
Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
[TBL] [Abstract][Full Text] [Related]
36. Correlation of CD44v6 expression with ovarian cancer progression and recurrence.
Shi J; Zhou Z; Di W; Li N
BMC Cancer; 2013 Apr; 13():182. PubMed ID: 23565736
[TBL] [Abstract][Full Text] [Related]
37. Standard and variant CD44 isoforms are commonly expressed in lung cancer of the non-small cell type but not of the small cell type.
Ariza A; Mate JL; Isamat M; López D; Von Uexküll-Güldeband C; Rosell R; Fernández-Vasalo A; Navas-Palacios JJ
J Pathol; 1995 Dec; 177(4):363-8. PubMed ID: 8568590
[TBL] [Abstract][Full Text] [Related]
38. Histological types and significance of bronchial epithelial dysplasia.
Wang GF; Lai MD; Yang RR; Chen PH; Su YY; Lv BJ; Sun LP; Huang Q; Chen SZ
Mod Pathol; 2006 Mar; 19(3):429-37. PubMed ID: 16415791
[TBL] [Abstract][Full Text] [Related]
39. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
Pirinen R; Hirvikoski P; Böhm J; Kellokoski J; Moisio K; Virén M; Johansson R; Hollmén S; Kosma VM
Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576
[TBL] [Abstract][Full Text] [Related]
40. Coexpression of EpCAM, CD44 variant isoforms and claudin-7 in anaplastic thyroid carcinoma.
Okada T; Nakamura T; Watanabe T; Onoda N; Ashida A; Okuyama R; Ito K
PLoS One; 2014; 9(4):e94487. PubMed ID: 24727741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
